ZNF419 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.849200E-01
Normal-vs-Stage2
4.081200E-01
Normal-vs-Stage3
2.245800E-01
Normal-vs-Stage4
6.581400E-01
Stage1-vs-Stage2
6.427800E-02
Stage1-vs-Stage3
1.406990E-01
Stage1-vs-Stage4
9.856000E-01
Stage2-vs-Stage3
5.287200E-01
Stage2-vs-Stage4
1.363620E-01
Stage3-vs-Stage4
2.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.501400E-01
Normal-vs-AfricanAmerican
3.040400E-01
Normal-vs-Asian
9.053500E-02
Caucasian-vs-AfricanAmerican
1.395380E-01
Caucasian-vs-Asian
1.317000E-01
AfricanAmerican-vs-Asian
8.016400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.314400E-01
Normal-vs-Female
4.390400E-01
Male-vs-Female
8.654200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.550000E-01
Normal-vs-Age(41-60Yrs)
5.030800E-01
Normal-vs-Age(61-80Yrs)
4.031200E-01
Normal-vs-Age(81-100Yrs)
3.687200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.243600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.483600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.145800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.450100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.227900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.486400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.394000E-01
Normal-vs-Daily Drinker
4.339000E-01
Normal-vs-Weekly Drinker
3.767600E-01
Normal-vs-Occasional Drinker
4.253800E-01
Normal-vs-Social Drinker
4.604000E-01
Non Drinker-vs-Daily Drinker
1.755160E-01
Non Drinker-vs-Weekly Drinker
6.126000E-01
Non Drinker-vs-Occasional Drinker
2.983000E-03
Non Drinker-vs-Social Drinker
9.167600E-02
Daily Drinker-vs-Weekly Drinker
5.243600E-01
Daily Drinker-vs-Occasional Drinker
1.037390E-01
Daily Drinker-vs-Social Drinker
7.733800E-01
Weekly Drinker-vs-Occasional Drinker
4.949900E-02
Weekly Drinker-vs-Social Drinker
3.351800E-01
Occasional Drinker-vs-Social Drinker
1.803190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.804400E-01
Normal-vs-Grade 2
2.981400E-01
Normal-vs-Grade 3
2.754000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.250400E-01
Grade 1-vs-Grade 3
6.982400E-01
Grade 1-vs-Grade 4
3.804400E-01
Grade 2-vs-Grade 3
5.362200E-01
Grade 2-vs-Grade 4
2.981400E-01
Grade 3-vs-Grade 4
2.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.379000E-01
Normal-vs-NonDiabetic
4.762400E-01
Diabetic-vs-NonDiabetic
1.641770E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.690400E-01
Normal-vs-NoPancreatitis
4.364000E-01
Pancreatitis-vs-NoPancreatitis
3.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.482800E-01
Normal-vs-N1
4.174000E-01
N0-vs-N1
5.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.037600E-01
Normal-vs-TP53-NonMutant
4.671800E-01
TP53-Mutant-vs-TP53-NonMutant
7.032400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
